Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer (Q34049234)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer |
scientific article |
Statements
1 reference
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer (English)
1 reference
Ana Maria Gonzalez-Angulo
1 reference
Gordon B Mills
1 reference
Karen H Lu
1 reference
Bryan T J Hennessy
1 reference
Kirsten M Timms
1 reference
Mark S Carey
1 reference
Alexander Gutin
1 reference
Larissa A Meyer
1 reference
Darl D Flake
1 reference
Victor Abkevich
1 reference
Jennifer Potter
1 reference
Dmitry Pruss
1 reference
Pat Glenn
1 reference
Yang Li
1 reference
Jie Li
1 reference
Karen Smith McCune
1 reference
Maurie Markman
1 reference
Russell R Broaddus
1 reference
Jerry S Lanchbury
1 reference
6 July 2010
1 reference
1 reference
28
1 reference
22
1 reference
3570-3576
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference